PatientsVille.com Logo

PatientsVille

Rifinah Side Effects

Common Rifinah Side Effects


The most commonly reported Rifinah side effects (click to view or check a box to report):

Vomiting (6)
Alanine Aminotransferase Increased (4)
Abdominal Pain Upper (4)
Chills (4)
Asthenia (4)
Hepatocellular Injury (4)
Psoriasis (4)
Pyrexia (4)
Pruritus (4)
Insomnia (3)
Hepatitis (3)
Cholestatic Liver Injury (3)
Liver Function Test Abnormal (3)
Eosinophilia (3)
Nausea (3)
Paraesthesia (3)
Rash Maculo-papular (3)
Toxic Skin Eruption (3)
Weight Decreased (3)
Myalgia (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Rifinah Side Effects Reported to FDA

The following Rifinah reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Rifinah on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hallucination, Visual Impairment, Disorientation, Insomnia, Paraesthesia
This is a report of a 25-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: tuberculosis, who was treated with Rifinah (dosage: Dose:2 Unit(s), start time: 201312), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Hallucination
  • Visual Impairment
  • Disorientation
  • Insomnia
  • Paraesthesia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Rifinah treatment in female patients, resulting in hallucination side effect.

Cholestasis, Hepatitis, Jaundice, Myalgia, Abdominal Pain Upper, Vomiting, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
This report suggests a potential Rifinah Cholestasis, Hepatitis, Jaundice, Myalgia, Abdominal Pain Upper, Vomiting, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased side effect(s) that can have serious consequences. A 42-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: antibiotic prophylaxis and used Rifinah (dosage: NA) starting Jun 04, 2012. Soon after starting Rifinah the patient began experiencing various side effects, including:
  • Cholestasis
  • Hepatitis
  • Jaundice
  • Myalgia
  • Abdominal Pain Upper
  • Vomiting
  • Aspartate Aminotransferase Increased
  • Alanine Aminotransferase Increased
Drugs used concurrently: NA.The patient was hospitalized. Although Rifinah demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cholestasis, may still occur.

Abdominal Pain, Hepatitis, Liver Function Test Abnormal, Chills
This Abdominal Pain, Hepatitis, Liver Function Test Abnormal, Chills problem was reported by a health professional from FR. A 34-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On 2012 this consumer started treatment with Rifinah (dosage: NA). The following drugs were being taken at the same time:
  • Enbrel (2 Injections)
  • Cortancyl
  • Methotrexate
When commencing Rifinah, the patient experienced the following unwanted symptoms/side effects:
  • Abdominal Pain
  • Hepatitis
  • Liver Function Test Abnormal
  • Chills
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as abdominal pain, may become evident only after a product is in use by the general population.

Contusion, Pain, Lethargy, Skin Mass, Skin Lesion
This is a report of a 17-year-old female patient (weight: NA) from GB. The patient developed the following symptoms/conditions: tuberculosis and was treated with Rifinah (dosage: Rifampicin 300mg / Isoniazid 150mg) starting Aug 05, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Contusion
  • Pain
  • Lethargy
  • Skin Mass
  • Skin Lesion
This opens a possibility that Rifinah treatment could cause the above reactions, including contusion, and some female subjects may be more susceptible.


Neutropenia
A 22-year-old female patient (weight: NA) from FR with the following symptoms/conditions: skin reaction,enteritis started Rifinah treatment (dosage: NA) on 201306. Soon after starting Rifinah treatment, the subject experienced various side effects, including:
  • Neutropenia
Concurrently used drugs:
  • Remicade (Strength: 100 Mg ; Form: Powder For Perfusion?dose : Recieved First Two Injections)
This finding indicates that some female patients could be more vulnerable to Rifinah.

Psoriasis, Pruritus
A 65-year-old male patient from FR (weight: NA) experienced symptoms, such as: NA and was treated with Rifinah(dosage: NA). The treatment was initiated on May 15, 2013. After that a consumer reported the following side effect(s):
  • Psoriasis
  • Pruritus
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Rifinah efficacy:
  • Atarax
  • Onglyza
  • Enbrel
  • Lovenox
The patient was hospitalized.

Visual Acuity Reduced, Diplopia
In this report, Rifinah was administered for the following condition: pulmonary tuberculosis.A 83-year-old male consumer from FR (weight: NA) started Rifinah treatment (dosage: NA) on 201210.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Visual Acuity Reduced
  • Diplopia
A possible interaction with other drugs could have contributed to this reaction:
  • Ramipril
  • Carvedilol
  • Metformin
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Rifinah treatment could be related to the listed above side effect(s).

Hypoglycaemia, Erythema, Hot Flush
This is a report of the following Rifinah side effect(s):
  • Hypoglycaemia
  • Erythema
  • Hot Flush
A 50-year-old male patient from FR (weight: NA) presented with the following condition: NA and received a treatment with Rifinah (dosage: NA) starting: Jan 16, 2013.The following concurrently used drugs could have generated interactions:
  • Velmetia
  • Glimepiride
  • Glimepiride
  • Metformin
The patient was hospitalized.This report suggests that a Rifinah treatment could be associated with the listed above side effect(s).

Hepatocellular Injury
This Rifinah report was submitted by a 38-year-old male consumer from FR (weight: NA). The patient was diagnosed with: tuberculosis and Rifinah was administered (dosage: NA) starting: Jan 26, 2013. The consumer developed a set of symptoms:
  • Hepatocellular Injury
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Rifinah treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Tendon Pain, Arthralgia
This is a report of a possible correlation between Rifinah use and the following symptoms/side effect(s):
  • Tendon Pain
  • Arthralgia
which could contribute to an assessment of Rifinah risk profile.A 38-year-old male consumer from FR (weight: NA) was suffering from latent tuberculosis and was treated with Rifinah (dosage: 3 Tablets Daily Each Morning, 30 Mins Before Breakfast Dose:3 Unit(s)) starting Jan 15, 2013.Other concurrent medications: NA.

Prothrombin Time Shortened, Hepatitis, Jaundice, Pyrexia, Rash Morbilliform
A 80-year-old female patient from FR (weight: NA) presented with the following symptoms: tuberculosis and after a treatment with Rifinah (dosage: NA) experienced the following side effect(s):
  • Prothrombin Time Shortened
  • Hepatitis
  • Jaundice
  • Pyrexia
  • Rash Morbilliform
The treatment was started on Feb 12, 2013. Rifinah was used in combination with the following drugs:
  • Rocephine
The patient was hospitalized.This report could alert potential Rifinah consumers.

Visual Acuity Reduced, Diplopia
In this report, a 83-year-old male patient from FR (weight: NA) was affected by a possible Rifinah side effect.The patient was diagnosed with pulmonary tuberculosis. After a treatment with Rifinah (dosage: Dose:2 Unit(s), start date: 201210), the patient experienced the following side effect(s):
  • Visual Acuity Reduced
  • Diplopia
The following simultaneously used drugs could have led to this reaction:
  • Ramipril
  • Carvedilol
  • Metformin
The findings here stress that side effects should be taken into consideration when evaluating a Rifinah treatment.

C-reactive Protein Increased
This is a report of a 83-year-old male patient from FR (weight: NA), who used Rifinah (dosage: NA) for a treatment of tuberculosis. After starting a treatment on Feb 26, 2013, the patient experienced the following side effect(s):
  • C-reactive Protein Increased
The following drugs could possibly have interacted with the Rifinah treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Rifinah treatment could be related to side effect(s), such as C-reactive Protein Increased.

Unwanted Pregnancy
This unwanted pregnancy side effect was reported by a health professional from FR. A 31-year-old female patient (weight:NA) experienced the following symptoms/conditions: tuberculosis. The patient was prescribed Rifinah (dosage: NA), which was started on 201110. Concurrently used drugs:
  • Nexplanon (Strength: 68 Mg)
When starting to take Rifinah the consumer reported the following symptoms:
  • Unwanted Pregnancy
The patient was hospitalized. These side effects may potentially be related to Rifinah.

Hyperthyroidism, Hepatocellular Injury
This is a Rifinah side effect report of a 31-year-old female patient (weight:NA) from FR, suffering from the following symptoms/conditions: tuberculosis,pulmonary tuberculosis,lymph node tuberculosis, who was treated with Rifinah (dosage:NA, start time: Oct 20, 2012), combined with:
  • Rifater
  • Rifater
, and developed a serious reaction and a hyperthyroidism side effect. The patient presented with:
  • Hyperthyroidism
  • Hepatocellular Injury
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Rifinah treatment in female patients suffering from tuberculosis,pulmonary tuberculosis,lymph node tuberculosis, resulting in hyperthyroidism.

Genital Infection, Pruritus, Acne, Exposure During Pregnancy
This report suggests a potential Rifinah genital infection side effect(s) that can have serious consequences. A 44-year-old female patient from FR (weight:NA) was diagnosed with the following health condition(s): tuberculosis and used Rifinah (dosage: NA) starting Mar 03, 2011. Soon after starting Rifinah the patient began experiencing various side effects, including:
  • Genital Infection
  • Pruritus
  • Acne
  • Exposure During Pregnancy
Drugs used concurrently:
  • Rifadine (Syrup 100 Mg)
Although Rifinah demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as genital infection, may still occur.

Ataxia, Tremor, Somnolence
This ataxia problem was reported by a pharmacist from ES. A 78-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): tuberculosis.On Apr 27, 2012 a consumer started treatment with Rifinah (dosage: NA). The following drugs/medications were being taken at the same time:
  • Pyrazinamide
  • Myambutol
  • Omeprazole
  • Sintrom
  • Manidipine Hydrochloride
When commencing Rifinah, the patient experienced the following unwanted symptoms /side effects:
  • Ataxia
  • Tremor
  • Somnolence
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as ataxia, may become evident only after a product is in use by the general population.

Jaundice Cholestatic
This is a Rifinah side effect report of a 80-year-old male patient (weight: NA) from TW. The patient developed the following symptoms/conditions: tuberculosis and was treated with Rifinah (dosage: 2 # Units Of Rifinah) starting Nov 20, 2011. Concurrently used drugs:
  • Amaryl
  • Acetylsalicylic Acid
  • Baktar
  • Pyridoxine
  • Ciprofloxacin
  • Cravit
  • Lanoxin
  • Myambutol
Soon after that, the consumer experienced the following of symptoms:
  • Jaundice Cholestatic
The patient was hospitalized. This opens a possibility that Rifinah could cause jaundice cholestatic and that some male patients may be more susceptible.

Toxic Skin Eruption, Scab, Wound, Wound Secretion, Eczema, Rash Erythematous, Pruritus, Dermatitis
A 63-year-old male patient (weight: NA) from ES with the following symptoms: lung disorder,tuberculosis started Rifinah treatment (dosage: Dose: 300+150 Mg 2 Tablets In 24 Hours) on Apr 25, 2012. Soon after starting Rifinah treatment, the consumer experienced several side effects, including:
  • Toxic Skin Eruption
  • Scab
  • Wound
  • Wound Secretion
  • Eczema
  • Rash Erythematous
  • Pruritus
  • Dermatitis
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Rifinah side effects, such as toxic skin eruption.

Circulatory Collapse
This circulatory collapse side effect was reported by a physician from INDIA. A 63-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Rifinah (rcinex E) (dosage: NA), which was started on Jan 31, 2012. Concurrently used drugs:
  • Omnipaque 140
.When starting to take Rifinah (rcinex E) the consumer reported symptoms, such as:
  • Circulatory Collapse
These side effects may potentially be related to Rifinah (rcinex E).

Biliary Cirrhosis Primary, Liver Function Test Abnormal, Food Aversion, Asthenia, Overdose, Muscle Spasms, Palpitations, Postural Orthostatic Tachycardia Syndrome, Syncope
This is a report of a 44-year-old male patient (weight: NA) from GB, suffering from the following symptoms/conditions: prophylaxis,tuberculosis, who was treated with Rifinah (dosage: Strength- Rifampicin 300mg+isoniazid 150 Mg, start time: 200110), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Biliary Cirrhosis Primary
  • Liver Function Test Abnormal
  • Food Aversion
  • Asthenia
  • Overdose
  • Muscle Spasms
  • Palpitations
  • Postural Orthostatic Tachycardia Syndrome
  • Syncope
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Rifinah treatment in male patients, resulting in biliary cirrhosis primary side effect.

Hypotension, Hypophosphataemia, Foetal Growth Restriction, Staphylococcal Infection, Anuria, Peritoneal Dialysis, Hypomagnesaemia, Device Malfunction, Oligohydramnios
This report suggests a potential Rifinah (isoniazid, Rifampicin) (isoniazid, Rifampicin) Hypotension, Hypophosphataemia, Foetal Growth Restriction, Staphylococcal Infection, Anuria, Peritoneal Dialysis, Hypomagnesaemia, Device Malfunction, Oligohydramnios side effect(s) that can have serious consequences. A female patient (weight: NA) from ITALY was diagnosed with the following symptoms/conditions: NA and used Rifinah (isoniazid, Rifampicin) (isoniazid, Rifampicin) (dosage: NA) starting Jun 01, 2010. Soon after starting Rifinah (isoniazid, Rifampicin) (isoniazid, Rifampicin) the patient began experiencing various side effects, including:
  • Hypotension
  • Hypophosphataemia
  • Foetal Growth Restriction
  • Staphylococcal Infection
  • Anuria
  • Peritoneal Dialysis
  • Hypomagnesaemia
  • Device Malfunction
  • Oligohydramnios
Drugs used concurrently:
  • Axeler (olmesartan Medoxomil, Amlodipine Besilate) (olmesartan Medoxom (Transplacental)
The patient was hospitalized. Although Rifinah (isoniazid, Rifampicin) (isoniazid, Rifampicin) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypotension, may still occur.

Connective Tissue Disorder, Rhinitis, Asthma, Superinfection, Myalgia, Pain, Sarcoidosis, Atypical Mycobacterium Test Positive, Antibiotic Resistant Staphylococcus Test Positive
This Connective Tissue Disorder, Rhinitis, Asthma, Superinfection, Myalgia, Pain, Sarcoidosis, Atypical Mycobacterium Test Positive, Antibiotic Resistant Staphylococcus Test Positive problem was reported by a health professional from FRANCE. A 16-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: lymphogranuloma venereum. On Dec 13, 2010 this consumer started treatment with Rifinah (rifinah) (dosage: Po). The following drugs were being taken at the same time:
  • Rifater (Po)
  • Solupred
  • Symbicort
  • Ventolin
  • Pyostacine
  • Ibuprofen (Po)
  • Prednisone (60 Mg;qd;po, 40 Mg;qd;po, 20 Mg;qd;po)
  • Prednisone (60 Mg;qd;po, 40 Mg;qd;po, 20 Mg;qd;po)
When commencing Rifinah (rifinah), the patient experienced the following unwanted symptoms/side effects:
  • Connective Tissue Disorder
  • Rhinitis
  • Asthma
  • Superinfection
  • Myalgia
  • Pain
  • Sarcoidosis
  • Atypical Mycobacterium Test Positive
  • Antibiotic Resistant Staphylococcus Test Positive
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as connective tissue disorder, may become evident only after a product is in use by the general population.

Haemothorax, Coma, Overdose, Gastrointestinal Haemorrhage, Shock Haemorrhagic, Gastritis Erosive
This is a report of a 40-year-old male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Rifinah (dosage: NA) starting NS. Concurrently used drugs:
  • Levothyrox
  • Hydrocortisone
  • Oxazepam
  • Imovane
  • Coumadin
Soon after that, the consumer experienced the following side effects:
  • Haemothorax
  • Coma
  • Overdose
  • Gastrointestinal Haemorrhage
  • Shock Haemorrhagic
  • Gastritis Erosive
The patient was hospitalized. This opens a possibility that Rifinah treatment could cause the above reactions, including haemothorax, and some male subjects may be more susceptible.

Abdominal Pain Upper, Acute Hepatic Failure, Fatigue, International Normalised Ratio Increased, Stupor, Vomiting
A 58-year-old female patient (weight: NA) from SWITZERLAND with the following symptoms/conditions: NA started Rifinah treatment (dosage: NA) on Sep 06, 2010. Soon after starting Rifinah treatment, the subject experienced various side effects, including:
  • Abdominal Pain Upper
  • Acute Hepatic Failure
  • Fatigue
  • International Normalised Ratio Increased
  • Stupor
  • Vomiting
Concurrently used drugs:
  • Triatec
  • Myambutol
  • Pyrazinamid ^sad^
  • Plendil
  • Aspirin
  • Torasemide
  • Calcitriol
The patient was hospitalized and became disabled. This finding indicates that some female patients could be more vulnerable to Rifinah.

1 of 3 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Rifinah Side Effects

    Did You Have a Rifinah Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Rifinah for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective